Advertisement

Occult Mechanisms of Brain Dysfunction

  • John W. Olney
Part of the Advances in Behavioral Biology book series (ABBI, volume 8)

Abstract

It is clear from Dr. Millichap’s presentation that important advances in the diagnosis and treatment of seizure disorders and minimal brain dysfunction syndromes have been realized in recent years. Unfortunately, significant progress toward the companion goal of prevention remains seriously hampered by our poor understanding of the etiology and pathogenesis of these conditions. Genetic factors undoubtedly play at least a predispositional role in many cases, but the potential contribution of an adverse environment deserves constant emphasis, particularly in that corrective measures are more easily brought to bear upon the environment than upon the gene. Dr. Nair, in discussing the toxic effects of drugs upon the developing CNS, touched upon an important theme worth reiterating here; that, in contrast to the gross malformations which characteristically result from exposure to toxic agents in early stages of development, exceedingly subtle forms of brain damage capable of defying current methods of detection may occur from exposure in later developmental stages. Dr. Millichap indicated, and I think many would agree, that the more carefully one examines children with minimal brain dysfunction, the more convinced one becomes that some sort of subtle brain damage underlies these conditions.

Keywords

Brain Damage Arcuate Nucleus Brain Dysfunction Acidic Amino Acid Sulphur Amino Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abraham, R., Doughtery, W., Goldberg, L. and Coulston, F., 1971, The response of the hypothalamus to high doses of monosodium glutamate in mice and monkeys. Cytochemistry and ultrastructural study of lysosomal changes. Exp. Molec. Path. 15: 43.CrossRefGoogle Scholar
  2. Burde, R.M., Schainker, B. and Kayes, J., 1971, Monosodium glutamate: Acute effect of oral and subcutaneous administration on the arcuate nucleus of the hypothalamus in mice and rats, Nature 233: 58.PubMedCrossRefGoogle Scholar
  3. Coombs, J.S., Eccles, J.C. and Fatt, P., 1955, The specific ionic conductances and the ionic movements across the motoneuronal membrane that produce the inhibitory postsynaptic potential, J. Physiol. 130: 326.PubMedGoogle Scholar
  4. Curley, A., Hawk, R.E., Kimbrough, R.D., Nathenson, G. and Finberg, L., 1971, Dermal absorption of hexachlorophene in infants, Lancet, 2: 296.PubMedCrossRefGoogle Scholar
  5. Curtis, D.R. and Watkins, J.C., 1960, The excitation and depression of spinal neurons by structurally related amino acids, J. Neurochem. 6: 117.PubMedCrossRefGoogle Scholar
  6. Curtis, D.R. and Watkins, J.C., 1963, Acidic amino acids with strong excitatory actions on mammalian neurons, J. Physiol. 166: 1.PubMedGoogle Scholar
  7. Everly, J.L., 1971, Light microscopic examination of MSG-induced lesions in brain of fetal and neonatal rats, Anat. Rec. 169: 312.Google Scholar
  8. Gaines, T.B. and Kimbrough, R.D., 1971, The oral and dermal toxicity of hexachlorophene, Paper read at the 10th annual meeting of the Society of Toxicology in Washington, D.C., March 7–11.Google Scholar
  9. Himwich, W.A. and Peterson, I.M., 1954, Ingested sodium glutamate and plasma levels of glutamic acid, J. Appl. Physiol. 7: 196.PubMedGoogle Scholar
  10. Johnston, N. and Reynolds, W.A., 1972, Incidence and extent of brain lesions in mice following ingestion of MSG, Anat. Rec. 172: 354.Google Scholar
  11. Knittle, J.L. and Ginsberg-Feller, F., 1970, Cellular and metabolic alterations in obese rats treated with monosodium glutamate during the neonatal period, Bulletin Am. Peds. Soc. Gen. Meeting, Program Abstracts, p. 6.Google Scholar
  12. Lucas, D.R. and Newhouse, J.P., 1957, The toxic effect of sodium L-glutamate on the inner layers of the retina, AMA Arch. Ophth. 58: 193.CrossRefGoogle Scholar
  13. Matsuyan, S., 1970, Studies on experimental obesity in mice treated with MSG. Jap. J. Vet. Science 32: 206.Google Scholar
  14. Menkes, J.H., Alter, M., Steigleder, G.K., Weakley, D.R. and Sung, J.H., 1962, A sex-linked recessive disorder with retardation of growth, peculiar hair and focal cerebral and cerebellar degeneration, Pediatrics 29: 764.PubMedGoogle Scholar
  15. Murakami, U. and Inouye, M., 1971, Brain lesions in the mouse fetus caused by maternal administration of monosodium glutamate, Congenital Anomalies 11: 171.Google Scholar
  16. Olney, J.W., 1969, Brain lesions, obesity and other disturbances in mice treated with monosodium glutamate, Science 164: 719.PubMedCrossRefGoogle Scholar
  17. Olney, J.W., 1971a, Glutamate induced neuronal necrosis in the in- fant mouse hypothalamus. An electron microscopy study, J. Neuropath. Exp. Neurol. 30: 75.PubMedCrossRefGoogle Scholar
  18. Olney, J.W., 1971b, Monosodium glutamate effects, Science 172: 294.PubMedCrossRefGoogle Scholar
  19. Olney, J.W. and Ho, O.L., 1970, Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine, Nature 227: 609.PubMedCrossRefGoogle Scholar
  20. Olney, J.W. and Sharpe, L.G., 1969, Brain lesions in an infant mon- key treated with monosodium glutamate, Science 166: 386.PubMedCrossRefGoogle Scholar
  21. Olney, J.W., Ho, O.L. and Rhee, V., 1971, Cytotoxic effects of acidic and sulphur containing amino acids on the infant mouse central nervous system, Exp. Brain Res. 14: 61.PubMedCrossRefGoogle Scholar
  22. Olney, J.W., Sharpe, L.G. and Feigin, R.D., 1972a, Glutamate induced brain damage in infant primates, J. Neuropath. Exp. Neurol. 31: 464.PubMedCrossRefGoogle Scholar
  23. Olney, J.W., Ho, O.L., Rhee, V. and Schainker, B., 1972b, Cysteine induced brain damage in infant and fetal rodents, Brain Res. 45: 309.PubMedCrossRefGoogle Scholar
  24. Perez, V.J. and Olney, J.W., 1972, Accumulation of glutamate by arcuate nucleus of infant mouse hypothalamus, J. Neurochem. 19: 1777.PubMedCrossRefGoogle Scholar
  25. Pradhan, S.N. and Lynch, J.F., 1972, Behavioral changes in adult rats treated with monosodium glutamate in the neonatal stage, Arch. Int. Pharmacodyn. 197: 301.PubMedGoogle Scholar
  26. Price, J.C., Waelsch, H. and Putnam, T.J., 1943, DL-Glutamic acid hydrochloride in treatment of petit mal and psychomotor seizures, JAMA 122: 1153.CrossRefGoogle Scholar
  27. Redding, T.W., Shalley, A.V., Arimura, A. and Wakaboyashi, I., 1971, Effects of monosodium glutamate on some endocrine functions, Neuroendocrin. 8: 245.CrossRefGoogle Scholar
  28. Snapir, N., Robinson, B. and Perek, M., 1971, Brain damage in male domestic fowl treated with monosodium glutamate, Poultry Science 50: 5.CrossRefGoogle Scholar
  29. Wong, P.W.K. and Fresco, R., 1972, Tissue cystathionine in mice treated with cysteine and homoserine, Pediat. Res. 5: 172.CrossRefGoogle Scholar
  30. Yoshida, T., Tada, K., Mizuno, T., Wada, Y., Akabane, J., Ogasawara, J., Minagawa, A., Morikawa, T. and Okamura, T., 1964, A sex-linked disorder with mental and physical retardation characterized by cerebrocortical atrophy and increase of glutamic acid in the cerebrospinal fluid, Tohoku J. Med. Sci. 83: 26.Google Scholar

Copyright information

© Plenum Press, New York 1974

Authors and Affiliations

  • John W. Olney
    • 1
  1. 1.Department of PsychiatryWashington University School of MedicineSt. LouisUSA

Personalised recommendations